Bouisset N, Villard S, Legros A
Authors not listed · 2022
Medical wearables like glucose monitors add continuous EMF exposure to our bodies without adequate safety testing.
Plain English Summary
Researchers tested whether continuous glucose monitors (CGM) work accurately in people receiving hemodialysis treatment. They found the devices performed well, with 13.8% average error compared to standard blood tests. This matters because accurate glucose monitoring helps diabetic patients on dialysis manage their condition more effectively.
Why This Matters
While this study focuses on medical device accuracy rather than EMF health effects, it highlights an important reality about our increasingly connected healthcare landscape. Continuous glucose monitors are wireless devices that transmit data constantly, adding to our daily EMF exposure load alongside smartphones, WiFi networks, and other connected health devices. The science demonstrates that we're embedding more radiofrequency-emitting devices directly on and in our bodies without fully understanding long-term cumulative effects. What this means for you is that every new 'smart' medical device represents another source of chronic EMF exposure, often worn 24/7 in direct contact with your skin.
Exposure Information
Specific exposure levels were not quantified in this study.
Show BibTeX
@article{bouisset_n_villard_s_legros_a_ce4305,
author = {Unknown},
title = {Bouisset N, Villard S, Legros A},
year = {2022},
doi = {10.2337/dc22-0073},
}